Stephen P.A. Fodor is a native of Seattle, Washington. He received his B.S. in Biology and M.S. in Biochemistry from Washington State University and his Ph.D. in Chemistry at Princeton University. From 1986 to 1989, he was a National Institutes of Health postdoctoral fellow at The University of California, Berkeley, working on time-resolved spectroscopy of bacterial and plant pigments.
In 1989 he was recruited to the Affymax Research Institute in Palo Alto where he spearheaded the effort to develop high-density arrays of biological compounds. Dr. Fodor and colleagues were the first to develop and describe microarray technologies and combinatorial chemistry synthesis.
In 1993, Dr. Fodor co-founded Affymetrix where the chip technology has been used to synthesize many varieties of high density oligonucleotide arrays containing hundreds of thousands of DNA probes. These DNA chips have broad commercial applications and are now used in many areas of basic and clinical research including the detection of drug resistance mutations in infectious organisms, direct DNA sequence comparison of large segments of the human genome, the monitoring of multiple human genes for cancer associated mutations, the quantitative and parallel measurement of mRNA expression for thousands of human genes, and the physical and genetic mapping of the human genome.
In 2001, Dr. Fodor founded Perlegen, Inc., a new venture that applied the chip technology on uncovering the basic patterns of human diversity. The adoption of the technology by both commercial and research institutions for these and other applications continues to grow rapidly.
Related Links: www.affymetrix.com
Last Updated: Tue, Jun 6, 2006
|Video||Intellectual Property and Life Sciences||Steve Fodor||Affymetrix||02:15||02/2005|
|Video||Which Came First, the Market or the Technology?||Steve Fodor||Affymetrix||02:17||02/2005|
|Video||The Scientist vs. the Entrepreneur||Steve Fodor||Affymetrix||04:40||02/2005|